NCT01812980View on ClinicalTrials.gov

Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women

PHASE4CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
InfluenzaHuman Immunodeficiency Virus
Interventions
BIOLOGICAL

Trivalent Inactivated Influenza Vaccine

"WHO recommendation for influenza vaccines for 2013 for the Southern-hemisphere included the following vaccine strains:~* an A/California/7/2009 (H1N1)pdm09-like virus;~* an A/Victoria/361/2011 (H3N2)-like virus; - a B/Wisconsin/1/2010-like virus."

Trial Locations (1)

Unknown

Nrf/Dst Vpd Rmpru, Soweto

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

lead

University of Witwatersrand, South Africa

OTHER

NCT01812980 - Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women | Biotech Hunter | Biotech Hunter